Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Index funds provide broad diversification, predictable costs, and easy implementation, appealing to both beginners and seasoned investors.
24,105 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
When choosing where to park money or borrow, the smart move may be to use both banks. Dave Ramsey weighs Navy Federal...
New data shows just 44% graduate in four years, while more than half finish in five. The extra year can push debt hig...
What would a new Fed chair do if inflation stayed stubborn while growth slowed? This article imagines Chair Kevin War...
As 2026 unfolds, investors face a pivotal choice between Lyft and Uber Technologies. This article breaks down strateg...
Lawmakers pivot from buyer subsidies to boosting the nation’s housing stock. The road housing bill’s biggest breakthr...
TSMC projects rapid AI chip revenue growth through 2029. This article breaks down what that means for investors in 20...
On March 12, investors navigated a mixed session in stock market today, march as a multi-day rally cooled. Hims And H...
The (onon) 2026 earnings call offers critical clues about growth drivers, margin reset, and next steps for investors....
Fame brings attention and money, but resilience and smart planning separate long-term winners from flash-in-the-pan s...
SpaceX’s emergence as a top public company captures headlines, but sustainable value hinges on cash flow, strategy, a...
As pay-TV declines, Comcast may lean on first-party data to power targeted streaming ads. This article breaks down ho...